Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jacksonville, FL
NPI
1699779975
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
915 W Monroe St Ste 200
Jacksonville, FL, 32204
Phone (904) 384-2240
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
2,940 services
Medicare patients, 2024
669
Average age 75
Drug cost, 2024
$1.6M
4,776 prescriptions
Company payments, 2025
$1,215
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by J. G Evans was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 976 times for 470 patients. In total J. G Evans billed 2,940 services in 16 codes, and Medicare paid $144K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 976 | 470 | $11.58 | $11K |
| 99213 Office E&M - Established | Office | 763 | 452 | $61.57 | $47K |
| 99214 Office E&M - Established | Office | 667 | 245 | $86.76 | $58K |
| 76536 Ultrasound - Nonspecific | Office | 206 | 198 | $74.54 | $15K |
| 95251 Test - Miscellaneous | Office | 185 | 73 | $24.89 | $4,605 |
| 99203 Office E&M - New | Office | 65 | 65 | $75.61 | $4,915 |
| 96372 Injection Administration | Office | 36 | 18 | $9.82 | $354 |
By year: 2022 $147K for 3,024 services; 2023 $124K for 1,750 services; 2024 $144K for 2,940 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 216 | 187 | $2.98 | $644 |
| 83036 Blood Count | 145 | 128 | $9.63 | $1,396 |
| 80053 Clinical Chemistry | 144 | 132 | $10.47 | $1,508 |
| 80061 Clinical Chemistry | 135 | 118 | $13.28 | $1,792 |
| 84443 Clinical Chemistry | 95 | 91 | $16.77 | $1,593 |
| 84439 Clinical Chemistry | 95 | 91 | $9.00 | $855 |
| 82044 Clinical Chemistry | 74 | 73 | $6.15 | $455 |
| 82570 Clinical Chemistry | 74 | 73 | $5.11 | $378 |
| 83970 Clinical Chemistry | 17 | 16 | $41.21 | $701 |
| 82306 Clinical Chemistry | 13 | 13 | $29.55 | $384 |
Medicare prescription drug claims, 2024
In 2024, the drug J. G Evans prescribed most often to Medicare patients was Levothyroxine Sodium, with 718 prescriptions and refills. In total J. G Evans wrote 4,776 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 718 | 2,026 | 188 | $6,979 |
| Synthroid Levothyroxine Sodium | 352 | 871 | 77 | $32K |
| Atorvastatin Calcium Generic | 202 | 572 | 58 | $2,098 |
| Metformin Hcl Generic | 199 | 564 | 55 | $1,770 |
| Ozempic Semaglutide | 182 | 295 | 35 | $269K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 175 | 454 | 50 | $31K |
| Jardiance Empagliflozin | 170 | 329 | 40 | $192K |
| Januvia Sitagliptin Phosphate | 141 | 289 | 32 | $153K |
| Humalog Kwikpen U-100 Insulin Lispro | 121 | 273 | 37 | $33K |
| Tresiba Flextouch U-100 Insulin Degludec | 119 | 300 | 37 | $89K |
| Mounjaro Tirzepatide | 116 | 134 | 18 | $138K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 88 | 192 | 33 | $12K |
| Novolog Flexpen Insulin Aspart | 83 | 205 | 32 | $29K |
| Methimazole Generic | 81 | 194 | 22 | $600 |
| Trulicity Dulaglutide | 79 | 92 | 15 | $86K |
Brand drugs: 2,627 claims; generic drugs: 1,820 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid J. G Evans $1,215 ($1,215 in general payments such as food, travel and fees) from 22 companies. The largest payer was Insulet Corporation with $298.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 11 | $298 |
| Abbott Laboratories ABT | 13 | $257 |
| Beta Bionics, Inc. BBNX | 1 | $128 |
| Amgen Inc. AMGN | 3 | $67.83 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $65.28 |
| Novo Nordisk Inc NVO | 3 | $61.84 |
| Lilly USA, LLC LLY | 3 | $54.54 |
| Corcept Therapeutics CORT | 2 | $50.49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49.77 |
| Chiesi USA, Inc. | 1 | $34.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.